Apricus Biosciences Requests Approval of Vitaros(R) as a Treatment for Erectile Dysfunction in Europe
28 avr. 2011 10h06 HE
|
Seelos Therapeutics, Inc.
SAN DIEGO, April 28, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) announced today that it has filed a marketing application in Europe for Vitaros® as a...
Apricus Biosciences to Present at the FSX Investor Conference in San Francisco on April 28, 2011
27 avr. 2011 13h07 HE
|
Seelos Therapeutics, Inc.
SAN DIEGO, April 27, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences ("Apricus Bio") (Nasdaq:APRI) today announced that Ed Cox, Vice President Corporate Development and Investor Relations, will present...
Apricus Biosciences Building Strong Pipeline and Solid Financials, CEO, Dr. Bassam Damaj, Tells CEO/CFO Magazine
19 avr. 2011 10h34 HE
|
Seelos Therapeutics, Inc.
SAN DIEGO, April 19, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences ("Apricus Bio") (Nasdaq:APRI) (http://www.apricusbio.com/index.html) is building a strong product pipeline backed by a sound financial...
Apricus Biosciences Files for Orphan Drug Designation for RayVa(TM)
13 avr. 2011 13h11 HE
|
Seelos Therapeutics, Inc.
SAN DIEGO, April 13, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) announced today its filing with the U.S. Food & Drug Administration ("FDA") requesting orphan...
Apricus Biosciences' CEO Interviewed by WallStreetCorner.com
05 avr. 2011 12h16 HE
|
Seelos Therapeutics, Inc.
SAN DIEGO, April 5, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that Chairman, President and Chief Executive Officer,...
Apricus Biosciences Expands Patent Coverage in Mexico for Its Erectile Dysfunction Drug, Vitaros(R)
31 mars 2011 10h41 HE
|
Seelos Therapeutics, Inc.
SAN DIEGO, March 31, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI), announced today that the Mexican Patent Office ("MPO") will grant an additional patent for...
Apricus Biosciences Adopts Shareholder Rights Plan
24 mars 2011 09h53 HE
|
Seelos Therapeutics, Inc.
SAN DIEGO, March 24, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) announced today that its Board of Directors (the "Board") has adopted a Shareholder Rights Plan...
Apricus Biosciences Announces Poster Presentations on Progress of PrevOnco(TM) in Combination With NexACT(R) Technology at the American Association for Cancer Research 2011 Annual Meeting
22 mars 2011 09h53 HE
|
Seelos Therapeutics, Inc.
SAN DIEGO, March 22, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) announced today that it will present two posters at the American Association for Cancer Research...
Apricus Biosciences Announces Formation of Clinical Advisory Board as Part of Its Plans to Further the Clinical Development of Femprox(R)
15 mars 2011 09h55 HE
|
Seelos Therapeutics, Inc.
SAN DIEGO, March 15, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc., ("Apricus Bio") (Nasdaq:APRI) today announced the formation of a Male and Female Sexual Dysfunction Clinical Advisory Board...
Apricus Biosciences to Present at the Bio-Europe Spring 2011 Conference
10 mars 2011 09h57 HE
|
Seelos Therapeutics, Inc.
SAN DIEGO, March 10, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) (http://www.apricusbio.com) today announced that Linda Smibert, Vice President, Business...